alpha-methyl-m-tyrosine has been researched along with Coronary Disease in 1 studies
alpha-methyl-m-tyrosine: RN given refers to cpd without stereoisomeric designation; structure in Merck Index, 9th ed, #6004
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, L | 1 |
1 other study available for alpha-methyl-m-tyrosine and Coronary Disease
| Article | Year |
|---|---|
Mechanisms of local noradrenaline release in acute myocardial ischemia.
Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Heart; Male; Methyltyrosines; Norepi | 1987 |